The patent covering Op2Lysis’ O2L-001 innovation for the treatment of patients with a hemorrhagic stroke has been granted in the United States of America by the USPTO in July 2017.
A specific press release is available below
–> Click here <–
————————- Our team ————————-
“Our ambition is to become a leader in research and development for stroke.”
117, avenue Victor Hugo, 92100 Boulogne-Billancourt